Free Trial

Enlivex Therapeutics (ENLV) Earnings Date, Estimates & Call Transcripts

$1.49
+0.07 (+4.93%)
(As of 05/21/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Jun. 21Estimated
Actual EPS
(Mar. 29)
-$0.48 Missed By -$0.48
Skip Charts & View Estimated and Actual Earnings Data

ENLV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ENLV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Enlivex Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.21)($0.21)($0.21)
Q2 20241($0.21)($0.21)($0.21)
Q3 20241($0.21)($0.21)($0.21)
Q4 20241($0.21)($0.21)($0.21)
FY 20244($0.84)($0.84)($0.84)

ENLV Earnings Date and Information

Enlivex Therapeutics last posted its earnings data on March 29th, 2024. The reported ($0.48) EPS for the quarter. Enlivex Therapeutics has generated ($1.56) earnings per share over the last year (($1.56) diluted earnings per share). Earnings for Enlivex Therapeutics are expected to grow in the coming year, from ($0.86) to ($0.55) per share. Enlivex Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 21st, 2024 based off prior year's report dates.

Enlivex Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
6/21/2024
(Estimated)
------- 
3/29/2024Q4 2023-($0.48)($0.48)($0.48)--
11/9/2023Q3 2023($0.32)($0.32)-($0.32)--
9/1/2023Q2 2023($0.43)($0.37)+$0.06($0.37)--
6/26/2023Q1 2023($0.40)($0.40)----
6/16/2023Q1 2023($0.40)($0.39)+$0.01($0.39)--
3/31/2023Q4 2022-($0.39)($0.39)($0.39)--
12/5/2022Q3 2022($0.29)($0.31)($0.02)($0.31)--
8/22/2022Q2 2022($0.45)($0.54)($0.09)($0.54)--
5/27/2022Q1 2022($0.41)($0.45)($0.04)($0.45)--
4/29/2022Q4 2021-($0.26)($0.26)($0.26)--    
11/21/2021Q3($0.21)($0.19)+$0.02($0.19)--
8/9/2021Q2 2021($0.26)($0.17)+$0.09($0.17)--
6/1/2021Q1 2021($0.21)($0.19)+$0.02($0.19)--
4/30/2021Q4 2020-($0.43)($0.43)($0.43)--
10/30/2020Q3 2020($0.18)($0.16)+$0.02($0.16)--
8/14/2020Q2 2020($0.24)($0.23)+$0.01($0.23)--
5/18/2020Q1 2020($0.24)($0.07)+$0.17($0.07)--
4/30/2020Q4 2019-($0.28)($0.28)($0.28)--
11/14/2019Q3 2019-($0.23)($0.23)($0.23)--
7/26/2019Q2 2019-($0.14)($0.14)($0.14)--

Enlivex Therapeutics Earnings - Frequently Asked Questions

When is Enlivex Therapeutics's earnings date?

Enlivex Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 21st, 2024 based off last year's report dates. Learn more on ENLV's earnings history.

How much profit does Enlivex Therapeutics generate each year?

Enlivex Therapeutics (NASDAQ:ENLV) has a recorded net income of -$29.07 million. ENLV has generated -$1.56 earnings per share over the last four quarters.

What is Enlivex Therapeutics's EPS forecast for next year?

Enlivex Therapeutics's earnings are expected to grow from ($0.86) per share to ($0.55) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ENLV) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners